Adhesion to 90K (Mac-2 BP) as a mechanism for lymphoma drug resistance in vivo

Blood

Volumn 96, Issue 9, 2000, Pages 3282-3285

  Fornarini, B ^a   D'Ambrosio, C ^a   Natoli, C ^a   Tinari, N ^a   Silingardi, V ^a   Iacobelli, S ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOXORUBICIN; PROLACTIN; PROTEIN MAC 2 BP; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CELL ADHESION; CONTROLLED STUDY; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HODGKIN DISEASE; HUMAN; LEUKEMIA CELL LINE; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 0034329188     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.9.3282     Document Type: Article

References (22)

1. Rising serum lactate dehydrogenase often caused by granulocyte- or granulocyte-macrophages colony stimulating factor and not tumor progression in patients with lymphoma or myeloma
2. Detection of antigens recognized by a novel monoclonal antibody in tissue and serum from patients with breast cancer
3. The secreted tumor-associated antigen 90K is a potent immune stimulator
4. Cloning and characterization of a human MAC-2-binding protein, a new member of the superfamily defined by the macrophage scavenger receptor cysteine-rich domain
5. A tumor derived protein which provides T-cell co-stimulation through accessory-cell activation
6. LPS-dependent interaction of Mac-2 binding protein with immobilized CD14
7. Suppression of tumor growth in vivo by local and systemic 90K level increase
8. Interactions between galactin-3 and Mac-2-binding protein mediate cell-cell adhesion
9. Mac-2 binding protein is a cell-adhesive protein of the extracellular matrix which self-assembles into ring-like structures and bind β1 integrins. Collagens and fibronectin
10. 90K (Mac-2 BP) in human milk
11. Dynamic test with recombinant interferon-alpha-2b effect on 90K and other tumour-associated antigens in cancer patients without evidence of disease
12. Prognostic value of a novel circulating serum 90K antigen in breast cancer
13. Circulating immunostimulatory protein 90K and soluble interleukin-2-receptor in human ovarian cancer
14. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
15. Report of the committee on Hodgkin's disease staging classification
16. Differential effect on TCR:CD3 stimulation of a 90-kD glycopretein (gp90/Mac-2BP), a member of the scavenger receptor cysteine-rich domain protein family
17. Biochemical and biological characterization of lymphocyte regulatory molecules, V: Identification of an interleukin 2-producing human leukemia T cell line
18. 1 Integrin- and proteoglycan-mediated stimulation of T lymphoma cell adhesion and mitogen-activated protein kinase signaling by thrombospondin-1 and thrombospondin-1 peptides
19. Specific p53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients
20. Cell adhesion mediated drug resistance (CAM-DR): Role of integrins and resistance to apoptosis in human myeloma cell lines
21. Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivo